These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36813655)

  • 21. Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment.
    Gallo A; Béliard S; D'Erasmo L; Bruckert E
    Curr Atheroscler Rep; 2020 Aug; 22(11):63. PubMed ID: 32852651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants.
    Perera SD; Wang J; McIntyre AD; Dron JS; Hegele RA
    J Clin Lipidol; 2023; 17(1):87-93. PubMed ID: 36476373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.
    Young SG; Fong LG; Beigneux AP; Allan CM; He C; Jiang H; Nakajima K; Meiyappan M; Birrane G; Ploug M
    Cell Metab; 2019 Jul; 30(1):51-65. PubMed ID: 31269429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase.
    Al-Shali K; Wang J; Fellows F; Huff MW; Wolfe BM; Hegele RA
    Clin Biochem; 2002 Mar; 35(2):125-30. PubMed ID: 11983347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome.
    Paquette M; Hegele RA; Paré G; Baass A
    J Clin Lipidol; 2018; 12(2):506-510. PubMed ID: 29452893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase.
    Kristensen KK; Midtgaard SR; Mysling S; Kovrov O; Hansen LB; Skar-Gislinge N; Beigneux AP; Kragelund BB; Olivecrona G; Young SG; Jørgensen TJD; Fong LG; Ploug M
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6020-E6029. PubMed ID: 29899144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene.
    Rabacchi C; D'Addato S; Palmisano S; Lucchi T; Bertolini S; Calandra S; Tarugi P
    J Clin Lipidol; 2016; 10(4):915-921.e4. PubMed ID: 27578123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report.
    Lin MH; Tian XH; Hao XL; Fei H; Yin JL; Yan DD; Li T
    BMC Pregnancy Childbirth; 2020 May; 20(1):272. PubMed ID: 32375710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene.
    Buonuomo PS; Bartuli A; Rabacchi C; Bertolini S; Calandra S
    J Clin Lipidol; 2015; 9(2):265-70. PubMed ID: 25911085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe hypertriglyceridemia in a patient heterozygous for a lipoprotein lipase gene allele with two novel missense variants.
    Kassner U; Salewsky B; Wühle-Demuth M; Szijarto IA; Grenkowitz T; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Eur J Hum Genet; 2015 Sep; 23(9):1259-61. PubMed ID: 25585702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial chylomicronemia syndrome caused by compound heterozygous mutation of lipoprotein lipase gene: A case report and review of literature.
    Huang Y; Qin Y; Liao L; Lin F
    Clin Chim Acta; 2022 Dec; 537():112-117. PubMed ID: 36252692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome.
    Zhang Y; Zhou J; Zheng W; Lan Z; Huang Z; Yang Q; Liu C; Gao R; Zhang Y
    Lipids Health Dis; 2016 May; 15():88. PubMed ID: 27153815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic algorithm for familial chylomicronemia syndrome.
    Stroes E; Moulin P; Parhofer KG; Rebours V; Löhr JM; Averna M
    Atheroscler Suppl; 2017 Jan; 23():1-7. PubMed ID: 27998715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia.
    Rabacchi C; Pisciotta L; Cefalù AB; Noto D; Fresa R; Tarugi P; Averna M; Bertolini S; Calandra S
    Atherosclerosis; 2015 Jul; 241(1):79-86. PubMed ID: 25966443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.
    Di Filippo M; Marçais C; Charrière S; Marmontel O; Broyer M; Delay M; Merlin M; Nollace A; Valéro R; Lagarde M; Pruneta-Deloche V; Moulin P; Sassolas A
    PLoS One; 2014; 9(5):e96482. PubMed ID: 24788417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum HDL-C values: An extremely useful marker for differentiating homozygous lipoprotein lipase deficiency from severe hypertriglyceridemia with other causes in Japan: A meta-analysis based on literatures on Japanese homozygous lipoprotein lipase deficiency.
    Kobayashi J; Minamizuka T; Koshizaka M; Maezawa Y; Ono H; Yokote K
    Clin Chim Acta; 2021 Oct; 521():85-89. PubMed ID: 34242636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
    Martín-Campos JM; Julve J; Roig R; Martínez S; Errico TL; Martínez-Couselo S; Escolà-Gil JC; Méndez-González J; Blanco-Vaca F
    Clin Chim Acta; 2014 Feb; 429():61-8. PubMed ID: 24291057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.
    Plengpanich W; Young SG; Khovidhunkit W; Bensadoun A; Karnman H; Ploug M; Gårdsvoll H; Leung CS; Adeyo O; Larsson M; Muanpetch S; Charoen S; Fong LG; Niramitmahapanya S; Beigneux AP
    J Biol Chem; 2014 Jul; 289(28):19491-9. PubMed ID: 24847059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic.
    Rioja J; Ariza MJ; García-Casares N; Coca-Prieto I; Arrobas T; Muñiz-Grijalvo O; Mangas A; Ibarretxe D; Sánchez-Chaparro MÁ; Valdivielso P
    Eur J Clin Invest; 2020 Dec; 50(12):e13345. PubMed ID: 32649781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia.
    Baass A; Paquette M; Bernard S; Hegele RA
    J Intern Med; 2020 Apr; 287(4):340-348. PubMed ID: 31840878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.